Literature DB >> 16879583

Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma.

Jayter Silva Paula, Rodrigo Jorge, Rogério Alves Costa, Maria de Lourdes V Rodrigues, Ingrid U Scott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16879583     DOI： 10.1111/j.1600-0420.2006.00731.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN： 1395-3907


× No keyword cloud information.
  25 in total

Review 1.  Medical and surgical treatment of neovascular glaucoma.

Authors:  Lisa C Olmos; Richard K Lee
Journal:  Int Ophthalmol Clin       Date:  2011

2.  Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab.

Authors:  L C Olmos; M S Sayed; A L Moraczewski; S J Gedde; P J Rosenfeld; W Shi; W J Feuer; R K Lee
Journal:  Eye (Lond)       Date:  2015-12-18       Impact factor: 3.775

3.  Effect of intravitreal bevacizumab on iris vessels in neovascular glaucoma patients.

Authors:  Yosuke Sugimoto; Hideki Mochizuki; Hideaki Okumichi; Masaya Takumida; Michiya Takamatsu; Seiichi Kawamata; Yoshiaki Kiuchi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-06-04       Impact factor: 3.117

4.  Panretinal photocoagulation with simultaneous cryoretinopexy or intravitreal bevacizumab for neovascular glaucoma.

Authors:  Tomoaki Tatsumi; Shuichi Yamamoto; Juntaro Uehara; Takeshi Sugawara; Takayuki Baba; Masayuki Inoue; Hiroko Hata; Yoshinori Mitamura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-12-19       Impact factor: 3.117

5.  Intravitreal bevacizumab (avastin) as an adjuvant treatment in cases of neovascular glaucoma.

Authors:  Asaad A Ghanem; Amr M El-Kannishy; Ahmed S El-Wehidy; Amira F El-Agamy
Journal:  Middle East Afr J Ophthalmol       Date:  2009-04

6.  Intravitreal bevacizumab: an analysis of the evidence.

Authors:  Derrick P Smit; David Meyer
Journal:  Clin Ophthalmol       Date:  2007-09

7.  Intravitreal bevacizumab for posterior capsule neovascularization.

Authors:  Mansour Al-Mohaimeed; Saeed Al-Gehedan; Hassan Al Dhibi
Journal:  Saudi J Ophthalmol       Date:  2010-04-02

8.  Intravitreal bevacizumab for neovascular glaucoma.

Authors:  Deepta Vasudev; Michael P Blair; John Galasso; Rashmi Kapur; Thasarat Vajaranant
Journal:  J Ocul Pharmacol Ther       Date:  2009-10       Impact factor: 2.671

9.  Intravitreal bevacizumab in the treatment of neovascular glaucoma secondary to central retinal vein occlusion: a case report.

Authors:  Tarek Alasil; Michael E Rauser
Journal:  Cases J       Date:  2009-10-30

10.  Bevacizumab (Avastin) for the management of anterior chamber neovascularization and neovascular glaucoma.

Authors:  Dimitrios Brouzas; Antonios Charakidas; Marilita Moschos; Chryssanthi Koutsandrea; Michael Apostolopoulos; Stefanos Baltatzis
Journal:  Clin Ophthalmol       Date:  2009-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.